13 participants
Treatment of Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-11-17
- Start Date:
- 2019-02-05
- Completion:
- 2020-08-06
Conditions
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Homologous Recombination Deficiency (HRD)
Interventions
- DRUG